{"id":"https://openalex.org/W2980868069","doi":"https://doi.org/10.1093/jjco/hyz135","title":"Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)","display_name":"Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)","alternate_titles":[],"publication_year":2019,"publication_date":"2019-10-15","ids":{"openalex":"https://openalex.org/W2980868069","doi":"https://doi.org/10.1093/jjco/hyz135","mag":"2980868069","pmid":"https://pubmed.ncbi.nlm.nih.gov/31612909","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6935297"},"language":"en","primary_location":{"id":"doi:10.1093/jjco/hyz135","doi":"https://doi.org/10.1093/jjco/hyz135","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jjco/hyz135","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2980868069"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1093/jjco/hyz135","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008549101","display_name":"Hiroji Iwata","orcid":"https://orcid.org/0000-0002-0242-4718","observed_orcids":["https://orcid.org/0000-0002-0242-4718"]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hiroji Iwata","raw_affiliation_strings":["Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan","institution_ids":["https://openalex.org/I4210133851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100785002","display_name":"Kenichi Inoue","orcid":"https://orcid.org/0000-0003-2686-8732","observed_orcids":["https://orcid.org/0000-0003-2686-8732"]},"institutions":[{"id":"https://openalex.org/I4210123465","display_name":"Saitama Cancer Center","ror":"https://ror.org/03a4d7t12","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123465"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenichi Inoue","raw_affiliation_strings":["Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan","institution_ids":["https://openalex.org/I4210123465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109179039","display_name":"Koji Kaneko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092137","display_name":"Niigata Cancer Center Hospital","ror":"https://ror.org/00e18hs98","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210092137"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Koji Kaneko","raw_affiliation_strings":["Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan","institution_ids":["https://openalex.org/I4210092137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101024720","display_name":"Yoshinori Ito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshinori Ito","raw_affiliation_strings":["Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064748731","display_name":"Koichiro Tsugawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]},{"id":"https://openalex.org/I4405285607","display_name":"St. Marianna University Hospital","ror":"https://ror.org/05ryk9w06","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405285607"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Koichiro Tsugawa","raw_affiliation_strings":["Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine Hospital, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine Hospital, Kanagawa, Japan","institution_ids":["https://openalex.org/I163917720","https://openalex.org/I4405285607"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ayumi Hasegawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ayumi Hasegawa","raw_affiliation_strings":["Chugai Pharmaceutical Co, Ltd, Tokyo, Japan, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chugai Pharmaceutical Co, Ltd, Tokyo, Japan, and","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102413267","display_name":"Shintaro Nakagawa","orcid":"https://orcid.org/0009-0000-8433-6801","observed_orcids":["https://orcid.org/0009-0000-8433-6801"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shintaro Nakagawa","raw_affiliation_strings":["Chugai Pharmaceutical Co, Ltd, Tokyo, Japan, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chugai Pharmaceutical Co, Ltd, Tokyo, Japan, and","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031705052","display_name":"Hiroyasu Kuratomi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroyasu Kuratomi","raw_affiliation_strings":["Chugai Pharmaceutical Co, Ltd, Tokyo, Japan, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chugai Pharmaceutical Co, Ltd, Tokyo, Japan, and","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069272944","display_name":"Kenji Tamura","orcid":"https://orcid.org/0000-0002-3514-9927","observed_orcids":["https://orcid.org/0000-0002-3514-9927"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenji Tamura","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5008549101"],"corresponding_institution_ids":["https://openalex.org/I4210133851"],"apc_list":{"value":3604,"currency":"USD","value_usd":3604},"apc_paid":{"value":3604,"currency":"USD","value_usd":3604},"fwci":2.4698,"has_fulltext":true,"cited_by_count":51,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90865671,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"49","issue":"12","first_page":"1083","last_page":"1091"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8003000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8003000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.19210000336170197,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":1.0},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.722000002861023},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.8889999985694885},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8949999809265137},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9779999852180481},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7390000224113464},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6029999852180481},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8130000233650208},{"id":"https://openalex.org/keywords/stomatitis","display_name":"stomatitis","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9135875701904297},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9005991220474243},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6306765079498291},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5579163432121277},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5561505556106567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5305217504501343},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.49203774333000183},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31368887424468994},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.18025586009025574},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.09589865803718567},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.09537461400032043}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000418","descriptor_name":"Albumins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000418","descriptor_name":"Albumins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/jjco/hyz135","doi":"https://doi.org/10.1093/jjco/hyz135","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jjco/hyz135","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6935297","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6935297/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6935297/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jpn J Clin Oncol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:5899157","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6935297","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:31612909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31612909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of clinical oncology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1093/jjco/hyz135","doi":"https://doi.org/10.1093/jjco/hyz135","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jjco/hyz135","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2980868069.pdf","grobid_xml":"https://content.openalex.org/works/W2980868069.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1861204180","https://openalex.org/W1994993231","https://openalex.org/W2037418758","https://openalex.org/W2100413206","https://openalex.org/W2101979288","https://openalex.org/W2124427232","https://openalex.org/W2126275851","https://openalex.org/W2137853125","https://openalex.org/W2143459396","https://openalex.org/W2155884390","https://openalex.org/W2170566133","https://openalex.org/W2173764926","https://openalex.org/W2560367415","https://openalex.org/W2560635244","https://openalex.org/W2561642944","https://openalex.org/W2585440566","https://openalex.org/W2592505613","https://openalex.org/W2605489431","https://openalex.org/W2616059838","https://openalex.org/W2733369216","https://openalex.org/W2743639018","https://openalex.org/W2794165047","https://openalex.org/W2796557635","https://openalex.org/W2806830990","https://openalex.org/W2807391987","https://openalex.org/W2889746019","https://openalex.org/W2897422388","https://openalex.org/W2897523860","https://openalex.org/W2898684787","https://openalex.org/W3021359142","https://openalex.org/W4234050115","https://openalex.org/W4239051461"],"related_works":["https://openalex.org/W2979347402","https://openalex.org/W4283461140","https://openalex.org/W2991189413","https://openalex.org/W2944446380","https://openalex.org/W3014206773","https://openalex.org/W2898451156","https://openalex.org/W4221038606","https://openalex.org/W3175173749","https://openalex.org/W2948023810","https://openalex.org/W3173705400"],"abstract_inverted_index":{"BACKGROUND:":[0],"In":[1,165],"the":[2,30,51,60,113,166,191,199,217,223,237,253,270],"randomised":[3,83],"Phase":[4],"3":[5],"IMpassion130":[6,61,255],"trial,":[7],"atezolizumab":[8],"combined":[9],"with":[10,18,41,76,196,252,267],"nab-paclitaxel":[11],"(atezo":[12,149,174],"+":[13,46,57,89,93,124,128,138,142,150,156,175,181,225,239,244],"nab-P)":[14,151,176],"in":[15,28,59,112,190,198,222,236,247],"902":[16],"patients":[17,66,121,135,221,235,249],"triple-negative":[19],"breast":[20],"cancer":[21],"(TNBC)":[22],"showed":[23],"prolonged":[24],"progression-free":[25],"survival":[26,102],"(PFS)":[27],"both":[29],"intention-to-treat":[31],"(ITT)":[32],"population":[33,104],"and":[34,53,100,105,232,263],"programmed":[35],"death-ligand":[36],"1":[37],"(PD-L1)-positive":[38],"subgroup":[39,132,193,204],"compared":[40],"placebo":[42],"plus":[43],"nab-P":[44,58,90,226,240,245],"(plac":[45,155,180],"nab-P).":[47,129,143],"This":[48],"study":[49],"assessed":[50,111],"efficacy":[52,246],"safety":[54,259],"of":[55,209,269],"atezo":[56,88,123,137,224],"Japanese":[62,114,120,192,203,248],"subpopulation.":[63,115],"METHODS:":[64],"Eligible":[65],"had":[67,205,228],"unresectable":[68],"locally":[69],"advanced":[70],"or":[71,91],"metastatic":[72,79],"TNBC":[73],"previously":[74],"untreated":[75],"chemotherapy":[77],"for":[78],"disease.":[80],"Patients":[81],"were":[82,97,109,118,194,261],"1:1":[84],"to":[85,213],"receive":[86],"either":[87],"plac":[92,127,141,238],"nab-P.":[94],"Co-primary":[95],"endpoints":[96],"investigator-assessed":[98],"PFS":[99,145,170],"overall":[101,200,218,254,271],"(ITT":[103],"PD-L1-positive":[106,131,167],"subgroup).":[107],"These":[108],"also":[110],"RESULTS:":[116],"There":[117],"65":[119],"(34":[122],"nab-P;":[125,139,157,182],"31":[126],"The":[130,202],"included":[133],"25":[134],"(12":[136],"13":[140],"Median":[144],"was":[146,171,250,265],"7.4":[147],"months":[148,154,173,179],"versus":[152,177],"4.6":[153],"hazard":[158],"ratio":[159],"[HR],":[160],"0.47;":[161],"95%":[162,185],"CI,":[163,186],"0.25-0.90).":[164],"subgroup,":[168],"median":[169],"10.8":[172],"3.8":[178],"HR,":[183],"0.04;":[184],"<0.01-0.35).":[187],"Safety":[188],"results":[189],"consistent":[195,251,266],"those":[197],"population.":[201,219,256,272],"a":[206],"lower":[207],"incidence":[208],"adverse":[210],"events":[211],"leading":[212],"treatment":[214],"withdrawal":[215],"than":[216,234],"More":[220],"arm":[227],"neutrophil":[229],"count":[230],"decreases":[231],"stomatitis":[233],"arm.":[241],"CONCLUSIONS:":[242],"Atezo":[243],"No":[257],"new":[258],"signals":[260],"observed,":[262],"tolerability":[264],"that":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2980868069","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-10-25T00:00:00"}
